Art. 13a Commission Regulation (EC) No 1234/2008 of 24 November 2008 concerning the examination o…

Notification procedure for minor variations of type IA

In forcesince 1 Jan 2025cited 2×
1.

Where a minor variation of type IA is made, the holder shall submit to the competent authority a notification containing the elements listed in Annex IV. This notification shall be submitted within 12 months following the implementation of the variation as an annual update for all minor variations of type IA or be submitted as part of grouping in accordance with Article 13d(2), first subparagraph, points (b) and (c), or as part of super-grouping of variations in accordance with Article 7a.

The notification shall be submitted immediately after the implementation of the variation in the case of minor variations requiring immediate notification for the continuous supervision of the medicinal product concerned.

By way of derogation from the first subparagraph, in justified cases, the competent authority of the Member State may accept the immediate submission of the notification after the implementation of the variation.

2.

Within 30 days following receipt of the notification, the measures provided for in Article 13e shall be taken.

  • Judgment of the Court (Third Chamber) of 1 October 2015. Agenzia Italiana del Farmaco (AIFA) and Ministero della Salute v Doc Generici srl.Decision

    Článek 13a nařízení č. 1234/2008, nadepsaný „Oznamovací postup pro malé změny typu IA“, stanoví: „1. Pokud dojde k malé změně typu IA, předloží držitel příslušnému orgánu oznámení, v němž jsou obsaženy …

    1 Oct 2015 · 62014CJ0452

  • Regulation (EU) 2024/1701Lawamends